greeksoup/ stock research

Albemarle (ALB) FY2025 results: revenue $5.1 billion, down 4.4% on the year

Albemarle Corp. (ALB) reported revenue of $5.1 billion for fiscal 2025, the year ended 31 December 2025, down 4.4% on the year before. Net income was -$511 million, and diluted earnings per share $-5.76. The figures are the company's own, from the 10-K it filed with the SEC on 11 February 2026.

Revenue
$5.1 billion
-4.4% on the year
FY2018FY2025
Operating margin
-7.1%
-33.0% a year earlier
FY2018FY2025
Net income
-$511 million
FY2018FY2025
Diluted EPS
-$5.76
FY2018FY2025

this yearthe year beforeHover a bar for its figure.

The year in brief

What management said about the year

Guidance figures: 12 new.

  • Fourth-quarter sales rose 16%: Net sales were $1.4 billion, up 16%, with volume up 12%. Management said gains came in all segments, led by Energy Storage and Ketjen.
  • Net loss driven by one-time items: The fourth-quarter net loss of $414 million, or $3.87 per diluted share, reflected tax-related items and a write-down tied to the expected Ketjen transaction. Adjusted loss was $0.53 per share.
  • Jordan flood hits 2026 production: A major flood at the Jordan Bromine Company joint venture in January 2026 is expected to affect 2026 production volume. The company said JBC has since returned to full operating rates.
  • Cost savings exceeded initial target: Management said it achieved about $450 million of cost and productivity improvements, above the initial $300 to $400 million target.
  • Improved lithium conditions cited: Management said the new scenarios highlight improved lithium market conditions and operational performance, and introduced 2026 ranges built on them.
Read the Q4 FY2025 earnings call summary

From this 10-K

Albemarle turns mined and brine-sourced minerals, mainly lithium and bromine, into chemicals that other manufacturers build into their products. The end markets it lists are grid storage, automotive, aerospace, conventional energy, electronics, construction, agriculture and food, pharmaceuticals and medical devices. It was incorporated in Virginia in 1993 and is based in Charlotte, North Carolina. With its joint ventures it operates more than 25 production and research and development facilities around the world, and at 31 December 2025 it served approximately 1,900 customers in approximately 70 countries. It reported three segments during 2025: Energy Storage, Specialties and Ketjen.

Albemarle Corp., the 10-K for 2025

Albemarle turns mined and brine-sourced minerals, mainly lithium and bromine, into chemicals that other manufacturers build into their products. The end markets it lists are grid storage, automotive, aerospace, conventional energy, electronics, construction, agriculture and food, pharmaceuticals and medical devices. It was incorporated in Virginia in 1993 and is based in Charlotte, North Carolina. With its joint ventures it operates more than 25 production and research and development facilities around the world, and at 31 December 2025 it served approximately 1,900 customers in approximately 70 countries. It reported three segments during 2025: Energy Storage, Specialties and Ketjen.

Energy Storage

Basic lithium compounds, principally lithium carbonate, lithium hydroxide and lithium chloride. They go into lithium batteries for consumer electronics, electric vehicles, power grids and solar panels, and into high performance greases and the specialty glass used in appliances and electronics. The filing describes the global lithium market as highly competitive and expanding quickly, with new entrants including car makers, commodity traders, junior miners and large diversified miners, and names Sociedad Quimica y Minera de Chile, Sichuan Tianqi Lithium, Jiangxi Ganfeng Lithium, Rio Tinto, Pilbara Minerals and Tesla among its competitors. Pricing in the market is increasingly index-based.

Where the lithium comes from

Two routes. The company buys lithium concentrate from Windfield Holdings, a 49%-owned joint venture that owns Talison Lithium, owner of the Greenbushes mine in Australia, and from MARBL Lithium Joint Venture, an unincorporated venture it owns half of, which holds the Wodgina hard rock lithium project in Western Australia. It also produces lithium by solar evaporation from its own ponds at the Salar de Atacama in Chile and at Silver Peak, Nevada. Beyond those it holds mineral rights at Kings Mountain, North Carolina and undeveloped land with access to a lithium resource at Antofalla in Catamarca Province, Argentina.

Specialties

Bromine chemistry and the more specialised lithium products. Fire safety compounds are the largest strand: they raise the flame resistance of plastics so those plastics can be used in hot, demanding applications such as enclosures for consumer electronics, printed circuit boards, wire and cable, electrical connectors, textiles and foam insulation, and in renewable grid and electrified transport infrastructure. Other bromine products include elemental bromine, alkyl bromides, inorganic bromides, brominated powdered activated carbon and bromine fine chemicals, some used in food and water safety. The lithium specialties include butyllithium and lithium aluminium hydride, used in organic synthesis for steroid chemistry, vitamins, life sciences and pharmaceutical intermediates. The segment also makes cesium products for chemical and pharmaceutical customers and zirconium, barium and titanium products for pyrotechnics including airbag initiators, and it offers technical services and recycling of lithium-containing by-products. Bromine is sourced from Arkansas, supported by a brine rights leasing programme, and from the Dead Sea through Jordan Bromine Company Limited, a half-owned consolidated joint venture formed in 1999 with operations at Safi in Jordan. Lanxess, Israel Chemicals and Rio Tinto are named as its main competitors here.

Ketjen and its sale

Three product lines: Clean Fuels Technologies, mainly hydroprocessing catalysts that strip sulfur and nitrogen out of refinery feedstocks, together with isomerisation and alkylation catalysts; fluidized catalytic cracking catalysts and additives, which crack refinery streams into transport fuels and petrochemical feedstocks such as propylene and cut sulfur dioxide and nitrogen oxide emissions; and performance catalyst solutions, mainly organometallic co-catalysts and curatives. On 25 October 2025 the company agreed to divest control of the Refining Solutions business to ChemCat AcquisitionCo, LLC and contribute the remainder to a new partnership, ChemCat Holdings, LP, retaining the performance catalyst solutions business and common units initially representing a 49% interest. On 23 January 2026 it completed the separate sale of its 50% interest in Eurecat S.A. to Axens SA.

People

There were approximately 7,800 employees at 31 December 2025, including those of consolidated joint ventures: 3,100 or 40% in the United States and the Americas, 2,600 or 33% in Asia Pacific, 1,500 or 19% in Europe and 600 or 8% in the Middle East and elsewhere. Approximately 26% are represented by unions or works councils.

From Albemarle's annual report on Form 10-K for the year ended 31 December 2025. The filing

Written from the 10-K filed 11 February 2026: read the full 10-K.

The four quarters: Q1 FY2025 · Q2 FY2025 · Q3 FY2025 · Q4 FY2025

Income statement (profit and loss)

$ millionFY2025FY2024FY2023On the yearLast 8 years
Revenue5,1435,3789,617-4.4%
Cost of revenue4,4745,3158,431-15.8%
Gross profit66962.51,186+969.3%
Gross margin13.0%1.2%12.3%
Research and development51.486.785.7-40.7%
Selling, general and administrative550618910-11.0%
Operating income-367-1,777252
Operating margin-7.1%-33.0%2.6%
Pre-tax income-552-1,764247
Income tax15787.1430+80.1%
Effective tax raten/an/a174.4%
Net income-511-1,1791,573
Net margin-9.9%-21.9%16.4%
Diluted EPS-$5.76-$11.20$13.36
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2025FY2024FY2023On the yearLast 8 years
Operating cash flow1,2826881,325+86.4%
Capital expenditure5901,6812,155-64.9%
Free cash flow692-993-829
Free cash flow margin13.5%-18.5%-8.6%
Cash from investing-146-1,585-2,565
Cash from financing-8341,242624
Depreciation and amortisation659589430+11.9%
Share-based compensation40.332.136.5+25.3%
Dividends paid191189187+1.1%
Dividend per share$1.62$1.61$1.60+0.6%
Diluted shares, weighted118m118m118m+0.1%
Shares outstanding at period end118m118m117m+0.1%

Balance sheet

$ millionFY2025FY2024FY2023On the yearLast 8 years
Shareholders' equity9,5339,9629,412-4.3%
Non-controlling interest248238253+4.2%
Debt3,1943,5164,167-9.2%
Operating lease liabilities10399.5114+3.6%
Finance lease liabilities103114104-9.6%
Other liabilities3,1932,6814,221+19.1%
Total liabilities and equity16,37416,61018,271-1.4%
Fixed assets8,6129,3319,495-7.7%
Goodwill1,5001,5831,630-5.2%
Intangible assets214231262-7.2%
Investments64.360.6207+6.1%
Cash and equivalents1,6181,192890+35.7%
Receivables5947421,213-20.0%
Inventory1,1791,5032,161-21.5%
Other assets2,5931,9672,412+31.8%
Total assets16,37416,61018,271-1.4%

10-K for the year ended 31 December 2025, filed 11 February 2026: the filing.